Skip to content
10-Q

Quarterly Report

USANA HEALTH SCIENCES INC USNA

0000896264-25-000126

← back to feed
Filed
May 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 18.62M sh
Current Liabilities Q1 2025 · Mar 29, 2025 $137.38M
Current Liabilities Q1 2025 · Dec 28, 2024 $139.63M
Total Liabilities Q1 2025 · Mar 29, 2025 $162.72M
Total Liabilities Q1 2025 · Dec 28, 2024 $161.86M
Current Assets Q1 2025 · Mar 29, 2025 $281.39M
Current Assets Q1 2025 · Dec 28, 2024 $279.19M
Total Assets Q1 2025 · Mar 29, 2025 $746.6M
Total Assets Q1 2025 · Dec 28, 2024 $748.19M
Cash And Equivalents Q1 2025 · Dec 28, 2024 $181.77M
Cash And Equivalents Q1 2025 · Mar 30, 2024 $328.34M
Shares Diluted Q1 2025 · Mar 30, 2024 19.3M sh
Stock Repurchased Q1 2025 · Mar 30, 2024 $9.44M
Capex Q1 2025 · Mar 30, 2024 $3.2M
Operating Cash Flow Q1 2025 · Mar 30, 2024 $17.68M
Stockholders Equity Q1 2025 · Mar 30, 2024 $499.99M
Stockholders Equity Q1 2025 · Dec 30, 2023 $497.2M
Eps Diluted Q1 2025 · Mar 30, 2024 $0.86
Eps Basic Q1 2025 · Mar 30, 2024 $0.86
Sga Expense Q1 2025 · Mar 30, 2024 $64.3M
Net Income Q1 2025 · Mar 30, 2024 $16.54M
Operating Income Q1 2025 · Mar 30, 2024 $24.67M
Gross Profit Q1 2025 · Mar 30, 2024 $184.73M
Cost Of Revenue Q1 2025 · Mar 30, 2024 $43.07M
Revenue Q1 2025 · Mar 30, 2024 $227.8M